Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje
Iingcaphuno zeStock zeenkampani ezingama-71229 ngexesha langempela.
Iimakethe ze-Stock, ukuthengisana kwempahla namhlanje

Iingcaphuno zempahla

Imali icatshulwa kwi-intanethi

Imbali icatshulwa ngemali

Imali yerhwebo yemali

Izabelo zeStock

Inzuzo kwizabelo zenkampani

Iingxelo zemali

Izabelo zezabelo zeenkampani. Kuphi utyalo mali?

Novo Nordisk A/S inzuzo nganye ngesabelo

Ingeniso yekota yenkampani Novo Nordisk A/S, ingxelo ngengeniso yezabelo NOVO-B.CO kunyaka we-2024. Ngabe i-Novo Nordisk A/S ishicilela izitatimende zemali kwiiphonkwane kunye nokulahlekelwa?
Yongeza kumajethijethi
Ukongezwa kumajethi

I-Novo Nordisk A/S ipapasha nini ingxelo kunye nelahleko?

Inzuzo ye-Novo Nordisk A/S kunye ne-loss statement iyapapashwa kanye nekota, ingxelo yangoku yezimali ye-Novo Nordisk A/S yashicilelwa ngo-30/09/2018.

Iyintoni inzuzo kwizabelo ze Novo Nordisk A/S?

Ingeniso ehlawulwayo nganye ngeNovo Nordisk A/S yayingu-3.74 kr kwingxelo yokugqibela yezemali.

Ngabe i-Novo Nordisk A/S izakupapasha nini i-profit and loss statement?

Inzuzo elandelayo nenzuzo yokulahleka Novo Nordisk A/S iya kuba ngo-EtiMnga 2024.

Novo Nordisk A/S ngesabelo sombutho wezemali sisalathiso esibaliweyo sempumelelo yenkampani, ebotshelelwe kwixabiso lombutho uqobo. Umvuzo ngesabelo ngasinye - ixabiso elibaliweyo: inzuzo iyonke yexesha lokunika ingxelo yahlulwe ngenani lezabelo ezikhoyo. Kucacile ukuba i Novo Nordisk A/S ngesabelo ngasinye luphawu lwezezimali ixesha elithile. Inzuzo ye Novo Nordisk A/S - yonke inzuzo yenkampani ngexesha lokunika ingxelo.

Bonisa:
Ukuze

Inzuzo Novo Nordisk A/S

Inzuzo kuyo yonke inkampani Novo Nordisk A/S ibaluleke kakhulu kulawulo lwabaphathi kunezabelo zenkampani. Okubaluleke ngakumbi kubalo lwengeniso ngesabelo ngasinye. Elixabiso lisisiseko sokubala izahlulo kwaye ingaphezulu kwesidingo ngokuqwalaselwa ngabanini zabelo. Umhla wengxelo yengeniso ye- Novo Nordisk A/S isekwe ngumthetho kunye nemithetho yombutho. Imihla ye Novo Nordisk A/S iinkcazo zenzuzo yamaxesha asandula ukuboniswa kwitafile kunye negrafu yenkonzo yethu kwi-Intanethi.

Inzuzo yekota Novo Nordisk A/S

Umvuzo ngesabelo ngasinye Novo Nordisk A/S ibalwa ngokwahlulahlula umvuzo ngenani lezabelo kwinkampani. Imbuyekezo ngesabelo ngasinye se- Novo Nordisk A/S imiselwe ixesha elimisiweyo lemali kwaye iyahambelana nokuphuma kweengxelo zemali kwinkcitho yenkampani. Novo Nordisk A/S ingeniso ngesabelo sanamhlanje okanye isithuba sokugqibela sokuxela sinokubonwa kwitafile kumgca ophezulu. Novo Nordisk A/S ingeniso yekota yohlalutyo lwemali yingxelo yethutyana yonyaka-mali.

NOVO-B.CO umhla wokubika Iintlawulo nge share
Iintlawulo ngezabelo zibalwa ngokuhlula ngeniso engenayo (okanye inzuzo) ngenani lezabelo zenkampani.
Utshintsho kunyaka %
30/09/2018 3.74 DKK -
30/06/2018 4.26 DKK -
31/03/2018 4.4 DKK -
31/12/2017 3.36 DKK -

Novo Nordisk A/S ingeniso yekota nganye kwisabelo ngasinye yinzuzo eqikelelweyo yenkampani. Banokubaluleka okuphakathi phakathi kwabahlalutyi. Kodwa umvuzo wonyaka ngesabelo ngasinye ubaluleke kakhulu. Inzuzo yekota egqithileyo Novo Nordisk A/S namhlanje yimali ebhengezwe ngokusemthethweni ngekota yokugqibela. Utshintsho kwingeniso Novo Nordisk A/S yonyaka lixabiso lesalathiso elibonisa amandla enzuzo athelekiswa nexesha elifanayo kunyaka ophelileyo. Utshintsho ngaphakathi Novo Nordisk A/S inzuzo yekota ngokuthelekisa kunyaka ophelileyo inokubaluleka kwiinkampani ezineshishini lamaxesha athile. Kodwa olona phawu lubalulekileyo kwinkampani yinkqubela phambili yenzuzo.

Ukulungiselela umbono kunye nohlalutyo, sipapasha utshintsho kwinzuzo njengepesenti. Imbali yenzuzo ye Novo Nordisk A/S kule minyaka idlulileyo kunye namaxesha okunika ingxelo kukwitheyibhile "Inzuzo yekota". Novo Nordisk A/S imbali yengeniso yekota iyafumaneka kwi-intanethi kule minyaka ilishumi idlulileyo. Novo Nordisk A/S i-database yokufumana inzuzo kwi-intanethi yexesha elidlulileyo lihlanganiswa ukusuka kwimithombo esemthethweni eqinisekisiweyo ngalo lonke ixesha.

Iindleko zezabelo Novo Nordisk A/S

YezeMali Novo Nordisk A/S